We are live on ! Find out more
DMTK

DermTech, Inc. Common Stock

Delisted

DMTK was delisted on the 26th of June, 2024.

169 hedge funds and large institutions have $1.01B invested in DermTech, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 97 funds opening new positions, 43 increasing their positions, 20 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

646% more first-time investments, than exits

New positions opened: 97 | Existing positions closed: 13

167% more capital invested

Capital invested by funds: $380M → $1.01B (+$634M)

115% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 20

99% more funds holding

Funds holding: 85169 (+84)

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

24% more call options, than puts

Call options by funds: $35M | Put options by funds: $28.2M

Holders
169
Holders Change
+84
Holders Change %
+98.82%
% of All Funds
2.97%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
97
Increased
43
Reduced
20
Closed
13
Calls
$35M
Puts
$28.2M
Net Calls
+$6.8M
Net Calls Change
+$7.04M
Name Holding Trade Value Shares
Change
Change in
Stake
CG
76
Cutler Group
California
$650K +$659K +12,607 +6,304%
Russell Investments Group
77
Russell Investments Group
United Kingdom
$615K -$758K -14,494 -54%
State of Wisconsin Investment Board
78
State of Wisconsin Investment Board
Wisconsin
$579K
Tudor Investment Corp
79
Tudor Investment Corp
Connecticut
$569K +$586K +11,200 New
CC
80
Cannell & Co
New York
$552K +$569K +10,875 New
Squarepoint
81
Squarepoint
New York
$543K +$559K +10,694 New
RJFSA
82
Raymond James Financial Services Advisors
Florida
$536K +$552K +10,547 New
OC
83
Oppenheimer & Co
New York
$536K +$552K +10,562 New
EAM
84
Exos Asset Management
New York
$504K +$520K +9,933 New
TI
85
Trexquant Investment
Connecticut
$485K +$499K +9,550 New
CWM
86
Cedar Wealth Management
California
$483K -$46.4K -887 -9%
Stifel Financial
87
Stifel Financial
Missouri
$482K +$496K +9,490 New
MKA
88
M. Kulyk & Associates
Georgia
$461K +$475K +9,073 New
PPA
89
Parametric Portfolio Associates
Washington
$448K +$461K +8,818 New
BRWM
90
B. Riley Wealth Management
Tennessee
$443K +$456K +8,720 New
RhumbLine Advisers
91
RhumbLine Advisers
Massachusetts
$402K +$414K +7,909 New
UAS
92
United Asset Strategies
New York
$383K -$48.4K -925 -11%
EGM
93
Engineers Gate Manager
New York
$381K +$392K +7,500 New
PCM
94
Penserra Capital Management
California
$372K -$440K -8,417 -53%
WPC
95
White Pine Capital
Minnesota
$335K
Commonwealth Equity Services
96
Commonwealth Equity Services
Massachusetts
$334K +$344K +6,581 New
Royal Bank of Canada
97
Royal Bank of Canada
Ontario, Canada
$329K +$306K +5,853 +922%
LWM
98
Laidlaw Wealth Management
New York
$323K +$332K +6,350 New
SFP
99
Sandbox Financial Partners
Maryland
$319K +$323K +6,169 New
Bank of Nova Scotia
100
Bank of Nova Scotia
Ontario, Canada
$314K +$323K +6,178 New

DMTK Hedge Fund Activity: Q1 2021 in Review

169 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q1 2021, worth a combined $1.01B — up 167% from $380M a quarter earlier.

Buyers outnumbered sellers: 97 funds opened new DMTK positions and 13 closed out — a net gain of 84 holders — while 43 added to existing stakes and 20 trimmed.

The largest buyer was ISZO Capital Management, adding an estimated $70.5M. The largest seller was Farallon Capital Management, cutting an estimated $34.6M.

  • 169 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q1 2021, up from 85 in Q4 2020.
  • Funds reported $1.01B of DermTech, Inc. Common Stock stock for Q1 2021, up 167% quarter-over-quarter.
  • 97 funds opened new DermTech, Inc. Common Stock positions in Q1 2021 and 13 closed out, a net change of +84 holders.
  • The largest DermTech, Inc. Common Stock buyer in Q1 2021 was ISZO Capital Management, an estimated $70.5M added.
  • The largest DermTech, Inc. Common Stock seller in Q1 2021 was Farallon Capital Management, an estimated $34.6M sold.

Based on aggregated 13F filings for Q1 2021.